WELCOME TO The data analytics REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Evolving Considerations for Data Storage in Life Sciences
June 5, 2019
I'm For Real
Enter your details once to access all our information and resources
Cyberian Technologies is a full-service IT integration company. We specialize in improving technology efficiencies through proactive engagements in managed IT and project services.
whitePaper | December 19, 2022
When an Azure region is not available due to issues at the Datacenter level, this should not affect the availability of data. Hence, database replication is required to avoid data loss at any given point in time. Some Microsoft Azure regions do not support Azure database replication in different regions. (Refer to the image given below) To overcome this, manual replication of MySQL database using MySQL workbench is the only feasible option.
whitePaper | March 12, 2020
This point of view is an exploration of the possibilities engendered by rethinking the role of data scientists in the wake of industrial revolution. It might be claimed that current trends in industrial revolution reflect a paradigm shift towards data centric processing with data science playing an increasingly critical role. This point of view also explicitly highlights the potential role of Data scientists as an emerging phenomenon, and then to show some of the benefits that this role can bring as we move towards industrial disruption
whitePaper | August 1, 2022
The Graph database is fundamental to driving a much-needed breakthrough in the world of Master Data Management (MDM). Until now, traditional MDM systems have imposed strict rules and structures on how these projects are managed. This has cost enterprises dearly in terms of wasted time and resources and has been a major contributory factor to the failure of many MDM initiatives. Graph has changed all of that, allowing modern MDM platforms to completely redefine how master data is prepared for insight and used to deliver tangible business outcomes.
whitePaper | May 15, 2023
Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.
whitePaper | August 2, 2022
The volume of data has exploded across all sectors in the last decade. Enterprise data has grown enormously, and organizations must contend with more unstructured data than ever. In fact, 95 percent of businesses cite the need to manage unstructured data as a challenge.
whitePaper | June 29, 2022
For (oh so many) years, we’ve been hearing about the “promise” of big data. Much of the buzz focused on getting people prepared for the onslaught of bigger data sets – and what IT needed to do to help the business make sense of this information.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE